Treatment Of Radiation Retinopathy Trial

• Status: Unknown status
• Trial end date: 1969-12-31

Summary

The purpose of this study is to demonstrate a statistically significant improvement of visual acuity after treatment using either Lucentis® or Triamcinolone® compared to no treatment, in patients with radiation retinopathy.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: Leiden University Medical Center
• Collaborator: Novartis Pharmaceuticals
• Treatments: Ranibizumab; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide